> top > docs > PMC:7696151 > spans > 41501-42051 > annotations

PMC:7696151 / 41501-42051 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1175 282-285 Chemical denotes HCQ MESH:D006886
1176 169-189 Disease denotes rheumatoid arthritis MESH:D001172
1177 191-210 Disease denotes lupus erythematosus MESH:D008180
1178 220-238 Disease denotes Sjögren’s syndrome MESH:D012859
1179 363-420 Disease denotes autoimmune disease-dependent cardiovascular complications MESH:D002318
1180 487-500 Disease denotes hyperglycemia MESH:D006943
1181 502-516 Disease denotes hyperlipidemia MESH:D006949

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T55 142-162 Phenotype denotes auto-immune diseases http://purl.obolibrary.org/obo/HP_0002960
T56 169-189 Phenotype denotes rheumatoid arthritis http://purl.obolibrary.org/obo/HP_0001370
T57 363-381 Phenotype denotes autoimmune disease http://purl.obolibrary.org/obo/HP_0002960
T58 487-500 Phenotype denotes hyperglycemia http://purl.obolibrary.org/obo/HP_0003074
T59 502-516 Phenotype denotes hyperlipidemia http://purl.obolibrary.org/obo/HP_0003077

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T269 0-271 Sentence denotes Most of all, it showed immunosuppressive properties, allowing its employment (alone or in combination) in the first-line treatment of several auto-immune diseases, like rheumatoid arthritis, lupus erythematosus, primary Sjögren’s syndrome, and anti-phospholipid syndrome.
T270 272-550 Sentence denotes Moreover, HCQ was revealed to be effective in preclinical and clinical trials to dampening autoimmune disease-dependent cardiovascular complications (Figure 7), as well as in the amelioration of disease-independent hyperglycemia, hyperlipidemia, and gastrointestinal complaints.